Ligand profile
ZINC116981440
Virtual-screening candidate from ZINC.
Bound to: KP13_05459 — L-Ala-D/L-Glu epimerase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC116981440- UniProt (similar protein)
Q81IL5- Tanimoto
- 0.706
- Target protein
- KP13_05459
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 179.0
- −1 ≤ LogP ≤ 5 -0.81
- MW ≤ 500 Da 319.3
- LogP ≤ 5 -0.81
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 11
- TPSA ≤ 140 Ų 179.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
NCCCC[C@H](NC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)ONCCCC[C@H](NC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O
InChI=1S/C12H21N3O7/c13-6-2-1-3-7(10(18)19)14-12(22)15-8(11(20)21)4-5-9(16)17/h7-8H,1-6,13H2,(H,16,17)(H,18,19)(H,20,21)(H2,14,15,22)/t7-,8+/m0/s1InChI=1S/C12H21N3O7/c13-6-2-1-3-7(10(18)19)14-12(22)15-8(11(20)21)4-5-9(16)17/h7-8H,1-6,13H2,(H,16,17)(H,18,19)(H,20,21)(H2,14,15,22)/t7-,8+/m0/s1
ZZASEPMMGWJWOV-JGVFFNPUSA-NZZASEPMMGWJWOV-JGVFFNPUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- NSK
- Homolog
- Q81IL5
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC116981440 →
- ZINC ZINC20 ZINC116981440 →
- UniProt UniProt Q81IL5 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC116981440”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05459.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).